Literature DB >> 18701317

Cytokines as a key component of cancer-related inflammation.

Giovanni Germano1, Paola Allavena, Alberto Mantovani.   

Abstract

Inflammatory conditions in some tissues increase the risk of cancer. Cytokines and chemokines are components of an intensive dialog promoting angiogenesis, metastasis, subversion of adaptive immunity and changing response to hormones and to chemotherapeutic agents. Cytokines involved in cancer-related inflammation represent a target for innovative diagnostic and therapeutic strategies, and a future challenge for scientists and clinicians.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18701317     DOI: 10.1016/j.cyto.2008.07.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  128 in total

1.  Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways.

Authors:  Kongthawat Chairatvit; Ariyaphong Wongnoppavich; Sirinthip Choonate
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

2.  Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.

Authors:  Xin Shelley Wang; Qiuling Shi; Loretta A Williams; Li Mao; Charles S Cleeland; Ritsuko R Komaki; Gary M Mobley; Zhongxing Liao
Journal:  Brain Behav Immun       Date:  2010-03-29       Impact factor: 7.217

3.  The use of chemokine-releasing tissue engineering scaffolds in a model of inflammatory response-mediated melanoma cancer metastasis.

Authors:  Cheng-Yu Ko; Lanxiao Wu; Ashwin M Nair; Yi-Ting Tsai; Victor K Lin; Liping Tang
Journal:  Biomaterials       Date:  2011-10-22       Impact factor: 12.479

4.  Ascites IL-10 Promotes Ovarian Cancer Cell Migration.

Authors:  Denis Lane; Isabelle Matte; Perrine Garde-Granger; Paul Bessette; Alain Piché
Journal:  Cancer Microenviron       Date:  2018-07-23

5.  Dynamic interplay between tumour, stroma and immune system can drive or prevent tumour progression.

Authors:  R J Seager; Cynthia Hajal; Fabian Spill; Roger D Kamm; Muhammad H Zaman
Journal:  Converg Sci Phys Oncol       Date:  2017-07-28

6.  Elevated IL-13Ralpha2 in intestinal epithelial cells from ulcerative colitis or colorectal cancer initiates MAPK pathway.

Authors:  Debasmita Mandal; Alan D Levine
Journal:  Inflamm Bowel Dis       Date:  2010-05       Impact factor: 5.325

7.  Gambogic acid protects from endotoxin shock by suppressing pro-inflammatory factors in vivo and in vitro.

Authors:  Jing Geng; Shuyan Xiao; Zhonghui Zheng; Siyang Song; Lianru Zhang
Journal:  Inflamm Res       Date:  2012-10-14       Impact factor: 4.575

8.  Potentiating effects of GHRH analogs on the response to chemotherapy.

Authors:  Andrew V Schally; Roberto Perez; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 9.  Why not treat human cancer with interleukin-1 blockade?

Authors:  Charles A Dinarello
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

10.  The receptor RAGE: Bridging inflammation and cancer.

Authors:  Astrid Riehl; Julia Németh; Peter Angel; Jochen Hess
Journal:  Cell Commun Signal       Date:  2009-05-08       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.